PET Imaging of Dopamine D2 Receptors with [18F]Fluoroclebopride in Monkeys: Effects of Isoflurane- and Ketamine-Induced Anesthesia

[1]  A. Malhotra,et al.  Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach , 1998, Synapse.

[2]  A. Gjedde,et al.  Enhanced [3H]DOPA and [3H]Dopamine Turnover in Striatum and Frontal Cortex In Vivo Linked to Glutamate Receptor Antagonism , 1998, Journal of neurochemistry.

[3]  M. Nader,et al.  Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography , 1998, Synapse.

[4]  K. Sugiyama,et al.  Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases , 1997, Brain Research.

[5]  Robert H Mach,et al.  Use of Positron Emission Tomography to Study the Dynamics of Psychostimulant-Induced Dopamine Release , 1997, Pharmacology Biochemistry and Behavior.

[6]  N. Lindefors,et al.  Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex , 1997, Brain Research.

[7]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[8]  C. Meltzer,et al.  Quantification of Neuroreceptors in the Living Human Brain: III. D2-Like Dopamine Receptors: Theory, Validation, and Changes during Normal Aging , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  C. D. Arnett,et al.  Carbon-11 labelled ketamine-synthesis, distribution in mice and PET studies in baboons. , 1997, Nuclear medicine and biology.

[10]  Marc G Caron,et al.  Dopamine receptors and brain function , 1996, Neuropharmacology.

[11]  S. Cabib,et al.  Stress, depression and the mesolimbic dopamine system , 1996, Psychopharmacology.

[12]  M. Nader,et al.  Comparison of two fluorine‐18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: In vitro binding studies and positron emission tomography , 1996, Synapse.

[13]  J. Mantz,et al.  Is inhibition of dopamine uptake relevant to the hypnotic action of i.v. anaesthetics? , 1996, British journal of anaesthesia.

[14]  G. Pearlson,et al.  In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. , 1995, Archives of general psychiatry.

[15]  Nobuko Mataga,et al.  Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey , 1994, Brain Research.

[16]  F. Weiss,et al.  A ketamine mixture anesthetic inhibits neuroendocrine and behavioral consequences of cocaine administration , 1994, Brain Research.

[17]  J. Mantz,et al.  Effects of Volatile Anesthetics, Thiopental, and Ketamine on Spontaneous and Depolarizationevoked Dopamine Release from Striatal Synaptosomes in the Rat , 1994, Anesthesiology.

[18]  J S Fowler,et al.  Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Alan A. Wilson,et al.  Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone , 1993, Psychiatry Research.

[20]  R. Mach,et al.  18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography. , 1993, Journal of medicinal chemistry.

[21]  T. Morton,et al.  The use of [18F]4-fluorobenzyl iodide (FBI) in PET radiotracer synthesis: model alkylation studies and its application in the design of dopamine D1 and D2 receptor-based imaging agents. , 1993, Nuclear medicine and biology.

[22]  N. Volkow,et al.  Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers , 1993, Synapse.

[23]  R R MacGregor,et al.  GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  K. Någren,et al.  PET demonstrates different behaviour of striatal dopamine D‐1 and D‐2 receptors in early Parkinson's disease , 1990, Journal of neuroscience research.

[25]  David J. Schlyer,et al.  Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  N. Volkow,et al.  Effects of chronic cocaine abuse on postsynaptic dopamine receptors. , 1990, The American journal of psychiatry.

[27]  G. Pearlson,et al.  Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. , 1986, Science.

[28]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[29]  R. Roth,et al.  SEROTONIN AND DOPAMINE METABOLITES IN BRAIN REGIONS AND CEREBROSPINAL FLUID OF A PRIMATE SPECIES: EFFECTS OF KETAMINE AND FLUPHENAZINE , 1979, Journal of neurochemistry.

[30]  J. Kebabian,et al.  Multiple receptors for dopamine , 1979, Nature.

[31]  J. Leysen,et al.  A serotonergic component of neuroleptic receptors. , 1977, Archives internationales de pharmacodynamie et de therapie.

[32]  N. Volkow,et al.  Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects , 1998, Neuropsychopharmacology.

[33]  R. Baldessarini.  Dopamine Receptors and Clinical Medicine , 1997 .

[34]  P. Seeman,et al.  Dopamine receptors and the dopamine hypothesis of schizophrenia , 1987, Synapse.

[35]  B. Långström,et al.  Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease. , 1987, Advances in neurology.